CDC’s “Our Global Voices”: Looking back with pride… Looking ahead with Confidence
Nancy Messonnier, director of the CDC National Center for Immunization and Respiratory Diseases, provides a historical overview of CDC’s efforts to eliminate meningitis epidemics as a public health threat in sub-Saharan Africa, including through the use of MenAfriVac, “the first vaccine developed specifically for use in sub-Saharan Africa for children and young adults between ages one and 29 years against serogroup A meningococcal meningitis” (4/20).